Amin Dipti 4
4 · Lineage Cell Therapeutics, Inc. · Filed Apr 22, 2021
Insider Transaction Report
Form 4
Amin Dipti
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-04-20+90,000→ 90,000 totalExercise: $2.28Exp: 2031-04-19→ Common Shares (90,000 underlying)
Footnotes (1)
- [F1]This option shall vest in 36 monthly installments beginning on the one-month anniversary of the date of grant, subject to the reporting person's continuous service on the board of directors of the issuer.